GPD1L and hepatocellular carcinoma: Promoter hypermethylation of GPD1L has been associated with adverse clinicopathological features and reduced patient survival, indicating that promoter-methylation-mediated GPD1L inactivation may contribute to HCC progression [5,6,22].